N-myc functions in transcription development

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 75, Issue 4, 2005, Pages 340-352

  Hurlin, Peter J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

c myc; Development; Max; N Myc; Transcription

Indexed keywords

ONCOPROTEIN; PROTEIN C MYB;

APOPTOSIS; CARCINOGENESIS; CELL FUNCTION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; MALIGNANT TRANSFORMATION; MORPHOGENESIS; NONHUMAN; ONCOGENE C MYB; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW;

ABNORMALITIES; ANIMALS; EMBRYONIC DEVELOPMENT; GENE DELETION; HUMANS; MICE; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 32644454031     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.20059     Document Type: Review

References (140)

1. Adhikary S, Peukert K, Karsunky H, Beuger V, Lutz W, Elsasser HP, Moroy T, Eilers M. 2003. Miz1 is required for early embryonic development during gastrulation. Mol Cell Biol 23:7648-7657.
2. Adhikary S, Eilers M. 2005. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6:635-645.
3. Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359:423-426.
4. Amati B, Frank SR, Donjerkovic D, Taubert S. 2001. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta 1471:M135-145.
5. Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, Fatyol K, Fahlen S, Hydbring P, Soderberg O, Grummt I, Larsson LG, Wright AP. 2005. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol 7:303-310.
6. Askew DS, Ashmun RA, Simmons BC, Cleveland JL. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922.
7. Ayer DE, Kretzner L, Eisenman RN. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
8. Baudino TA, McKay C, Pendeville-Samain H, Nilsson JA, Maclean KH, White EL, Davis AC, Ihle JN, Cleveland JL. 2002. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev 16:2530-2543.
9. Beier R, Burgin A, Kiermaier A, Fero M, Karsunky H, Saffrich R, Moray T, Ansorge W, Roberts J, Eilers M. 2000. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. EMBO J 19:5813-5823.
10. Berns K, Hijmans EM, Koh E, Daley GQ, Bernards R. 2000. A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts. Oncogene. 19:3330-3334.
11. Bettess MD, Dubois N, Murphy MJ, Dubey C, Roger C, Robine S, Trumpp A. 2005. c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium. Mol Cell Biol 25:7868-7878.
12. Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J, Eilers M. 1999. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J 18:5321-5333.
13. Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Luscher B. 2001. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 15:2042-2047.
14. Boulet AM, Moon AM, Arenkiel BR, Capecchi MR. 2004. The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth. Dev Biol 273:361-372.
15. Brodeur GM, Saylors RL, 3rd. 1991. Neuroblastoma, retinoblastoma, and brain tumors in children. Curr Opin Oncol 3:485-496.
16. Cai CL, Zhou W, Yang L, Bu L, Qyang Y, Zhang X, Li X, Rosenfeld MG, Chen J, Evans S. 2005. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development 132:2475-2487.
17. Cardoso WV. 1995. Transcription factors and pattern formation in the developing lung. Am J Physiol 269:L429-L442.
18. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ, Wheeler R, Wong B, Drenkow J, Yamanaka M, Patel S, Brubaker S, Tammana H, Helt G, Struhl K, Gingeras TR. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116:499-509.
19. Charron J, Malynn BA, Fisher P, Stewart V, Jeannotte L, Goff SP, Robertson EJ, Alt FW. 1992. Embryonic lethality in mice homozygous for a targeted disruption of the N-mycgene. Genes Dev 6:2248-2257.
20. Charron J, Gagnon JF, Cadrin-Girard JF. 2002. Identification of N-myc regulatory regions involved in embryonic expression. Pediatr Res 51:48-56.
21. Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV. 1999. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet 22:102-105.
22. Christoffels VM, Hoogaars WM, Tessari A, Clout DE, Moorman AF, Campione M. 2004. T-box transcription factor Tbx2 represses differentiation and formation of the cardiac chambers. Dev Dyn 229:763-770.
23. Courtens W, Levi S, Verbelen F, Verloes A, Vamos E. 1997. Feingold syndrome: report of a new family and review. Am J Med Genet 73:55-60.
24. Davis AC, Wims M, Spotts GD, Hann SR, Bradley A. 1993. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev 7:671-682.
25. de Alboran IM, O'Hagan RC, Gartner F, Malynn B, Davidson L, Rickert R, Rajewsky K, DePinho RA, Alt FW. 2001. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14:45-55.
26. de la Cova C, Abril M, Bellosta P, Gallant P, Johnston LA. 2004. Drosophila myc regulates organ size by inducing cell competition. Cell 117:107-116.
27. Douglas NC, Jacobs H, Bothwell AL, Hayday AC. 2001. Defining the specific physiological requirements for c-Myc in T cell development. Nat Immunol 2:307-315.
28. Downs KM, Martin GR, Bishop JM. 1989. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev 3:860-869.
29. Eberhardy SR, Farnham PJ. 2001. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J Biol Chem. 276:48562-48571.
30. Eberhardy SR, Farnham PJ. 2002. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J Biol Chem 277:40156-40162.
31. Eisenman RN. 2001. Deconstructing myc. Genes Dev 15:2023-2030.
32. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
33. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B. 2003. Genomic targets of the human c-Myc protein. Genes Dev 17:1115-1129.
34. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B. 2001. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 15:2069-2082.
35. Giroux S, Charron J, 1998. Defective development of the embryonic liver in N-myc-deficient mice. Dev Biol 195:16-28.
36. Gomez-Roman N, Grandori C, Eisenman RN, White RJ. 2003. Direct activation of RNA polymerase III transcription by c-Myc. Nature 421:290-294,
37. Grandori C, Cowley SM, James LP, Eisenman RN. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16:653-699.
38. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, White RJ. 2005. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7:311-318.
39. Graus-Porta D, Blaess S, Senften M, Littlewood-Evans A, Damsky C, Huang Z, Orban P, Klein R, Schittny JC, Muller U. 2001. Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron. 31:367-379.
40. Gregory MA, Qi Y, Hann SR. 2003. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem. 278:51606-51612.
41. Grewal SS, Li L, Orian A, Eisenman RN, Edgar BA. 2005. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat Cell Biol 7:295-302.
42. Hann SR, Thompson CB, Eisenman RN. 1985. c-Myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 314:366-369.
43. Hatton KS, Mahon K, Chin L, Chiu FC, Lee HW, Peng D, Morgenbesser SD, Horner J, DePinho RA. 1996. Expression and activity of L-Myc in normal mouse development. Mol Cell Biol 16:1794-1804.
44. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
45. Herald S, Wanzel M, Beuger V, Frohme C, Beul D, Hillukkala T, Syvaoja J, Saluz HP, Haenel F, Eilers M. 2002. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 10:509-521.
46. Hirning U, Schmid P, Schulz WA, Rettenberger G, Hameister H. 1991. A comparative analysis of N-myc and c-myc expression and cellular proliferation in mouse organogenesis. Mech Dev 33:119-125.
47. Hirvonen H, Makela TP, Sandberg M, Kalimo H, Vuorio E, Alitalo K. 1990. Expression of the myc proto-oncogenes in developing human fetal brain. Oncogene 5:1787-1797.
48. Ho KS, Scott MP. 2002. Sonic hedgehog in the nervous system: functions, modifications and mechanisms. Curr Opin Neurobiol 12:57-63.
49. Honeycutt KA, Roop DR. 2004. c-Myc and epidermal stem cell fate determination. J Dermatol. 31:368-375.
50. Hong CS, Saint-Jeannet JP. 2005. Sox proteins and neural crest development. Semin Cell Dev Biol. 16:694-703.
51. Hornik C, Brand-Saberi B, Rudloff S, Christ B, Fuchtbauer EM. 2004. Twist is an integrator of SHH, FGF, and BMP signaling. Anat Embryol (Berl) 209:31-39.
52. Hurlin PJ, Queva C, Koskinen PJ, Steingrimsson E, Ayer DE, Copeland NG, Jenkins NA, Eisenman RN. 1995. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 14:5646-5659.
53. Hurlin PJ, Queva C, Eisenman RN. 1997. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev 11:44-58.
54. Hurlin PJ, Steingrimsson E, Copeland NG, Jenkins NA, Eisenman RN. 1999. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. EMBO J 18:7019-7028.
55. Hurlin PJ, Zhou ZQ, Toyo-oka K, Ota S, Walker WL, Hirotsune S, Wynshaw-Boris A. 2003. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J 22:4584-4596.
56. Iritani BM, Eisenman RN. 1999. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci USA 96:13180-13185.
57. Johnston LA, Prober DA, Edgar BA, Eisenman RN, Gallant P. 1999. Drosophila myc regulates cellular growth during development. Cell 98:779-790.
58. Kato GJ, Barrett J, Villa-Garcia M, Dang CV. 1990. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol 10:5914-5920.
59. Kenney AM, Cole MD, Rowitch DH. 2003. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 130:15-28.
60. Kenney AM, Widlund HR, Rowitch DH. 2004. Hedgehog and PI-3 kinase signaling converge on Nmycl to promote cell cycle progression in cerebellar neuronal precursors. Development 131:217-228.
61. Kim S, Li Q, Dang CV, Lee LA. 2000. Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proc Natl Acad Sci USA 97:11198-11202.
62. Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP. 2003. Skp2 regulates Myc protein stability and activity. Mol Cell 11:1177-1188.
63. Knoepfler PS, Cheng PF, Eisenman RN. 2002. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 16:2699-2712.
64. Kretzner L, Blackwood EM, Eisenman RN. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature 359:426-429.
65. Laufer E, Nelson CE, Johnson RL, Morgan BA, Tabin C. 1994. Sonic hedge-hog and Fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud. Cell 79:993-1003.
66. Lewandoski M, Sun X, Martin GR. 2000. Fgf8 signalling from the AER is essential for normal limb development. Nat Genet 26:460-463.
67. Litingtung Y, Dahn RD, Li Y, Fallon JF, Chiang C. 2002. Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity. Nature 418:979-983.
68. Lowe SW, Cepero E, Evan G. 2004. Intrinsic tumour suppression. Nature 432(7015):307-315.
69. Luscher B. 2001. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 277:1-14.
70. MacSM, D'Cunha CA, Farnham PJ. 2000 . Direct recruitment of N-myc to target gene promoters. Mol Carcinog 29:76-86.
71. Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH, Hannon GJ. 1999. Twist is a potential oncogene that inhibits apoptosis. Genes Dev 13:2207-2217.
72. Malynn BA, de Alboran IM, O'Hagan RC , Bronson R, Davidson L, DePinho RA, Alt FW. 2000. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 14:1390-1399.
73. Mariani FV, Martin GR. 2003. Deciphering skeletal patterning: clues from the limb. Nature 423:319-325.
74. Mateyak, M. K., Obaya, A. J., Adachi, S. and Sedivy, J. M. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 8:1039-1048.
75. Mazieres J, He B, You L, Xu Z, Jablons DM. 2005. Wnt signaling in lung cancer. Cancer Lett 222(1):1-10.
76. McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. 1998. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94:363-374.
77. McMahon SB, Wood MA, Cole MD. 2000. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol 20:556-562.
78. Meroni G, Reymond A, Alcalay M, Borsani G, Tanigami A, Tonlorenzi R, Nigro CL, Messali S, Zollo M, Ledbetter DH, Brent R, Ballabio A, Carrozzo R. 1997. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J 16:2892-2906.
79. Mill P, Mo R, Hu MC, Dagnino L, Rosenblum ND, Hui CC. 2005. Shh controls epithelial proliferation via independent pathways that converge on N-Myc. Dev Cell 9:293-303.
80. Moens CB, Auerbach AB, Conlon RA, Joyner AL, Rossant J. 1992. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes Dev 6:691-704.
81. Moens CB, Stanton BR, Parada LF, Rossant J. 1993. Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus. Development 119:485-499.
82. Moreno E, Basler K. 2004. dMyc transforms cells into super-competitors. Cell 117:117-129.
83. Morgenbesser SD, DePinho RA. 1994. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin Cancer Biol 5:21-36.
84. Mugrauer G, Alt FW, Ekblom P. 1988. N-myc proto-oncogene expression during organogenesis in the developing mouse as revealed by in situ hybridization. J Cell Biol 107:1325-1335.
85. Murphy MJ, Wilson A, Trumpp A. 2005. More than just proliferation: Myc function in stem cells. Trends Cell Biol 15:128-137.
86. Nagy A, Moens C, Ivanyi E, Pawling J, Gertsenstein M, Hadjantonakis AK, Pirity M, Rossant J. 1998. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr Biol 8:661-664.
87. Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD. 1985. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature 318:69-73.
88. Nikiforov MA, Kotenko I, Petrenko O, Beavis A, Valenick L, Lemischka I, Cole MD. 2000. Complementation of Myc-dependent cell proliferation by cDNA expression library screening. Oncogene 19:4828-4831.
89. Nikiforov MA, Chandriani S, Park J, Kotenko I, Matheos D, Johnsson A, McMahon SB, Cole MD. 2002. TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins. Mol Cell Biol 22:5054-5063.
90. Nilsson JA, Cleveland JL. 2003. Myc pathways provoking cell suicide and cancer. Oncogene 22:9007-9021.
91. Nilsson JA, Maclean KH, Keller UB, Pendeville H, Baudino TA, Cleveland JL. 2004. Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol Cell Biol 24:1560-1569.
92. Niswander L, Jeffrey S, Martin GR, Tickle C. 1994. A positive feedback loop coordinates growth and patterning in the vertebrate limb. Nature 371:609-612.
93. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839-843.
94. Okubo T, Hogan BL. 2004. Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm. J Biol 3:11.
95. Okubo T, Knoepfler PS, Eisenman RN, Hogan BL. 2005. Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation. Development 132:1363-1374.
96. Oliver TG, Grasfeder LL, Carroll AL, Kaiser C, Gillingham CL, Lin SM, Wickramasinghe R, Scott MP, Wechsler-Reya RJ. 2003. Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci USA 100:7331-7336.
97. Orian A, van Steensel B, Delrow J, Bussemaker HJ, Li L, Sawado T, Williams E, Loo LW, Cowley SM, Yost C, Pierce S, Edgar BA, Parkhurst SM, Eisenman RN. 2003. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev 17:1101-1114.
98. Oskarsson T, Trumpp A. 2005. The Myc trilogy: lord of RNA polymerases. Nat Cell Biol 7:215-217.
99. Park J, Kunjibettu S, McMahon SB, Cole MD. 2001. The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis. Genes Dev 15:1619-1624.
100. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB. 2004. Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 4:562-568.
101. Pelengaris S, Khan M, Evan G. 2002. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2:764-776.
102. Perez-Roger I, Kim SH, Griffiths B, Sewing A, Land H. 1999. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J 18:5310-5320.
103. Peukert K, Staller P, Schneider A, Carmichael G, Hanel F, Eilers M. 1997. An alternative pathway for gene regulation by Myc. EMBO J 16:5672-5686.
104. Queva C, Hurlin PJ, Foley KP, Eisenman RN. 1998. Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogene 16:967-977.
105. Sawai S, Kato K, Wakamatsu Y, Kondoh H. 1990. Organization and expression of the chicken N-myc gene. Mol Cell Biol 10:2017-2026.
106. Sawai S, Shimono A, Hanaoka K, Kondoh H. 1991. Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. New Biol 3:861-869.
107. Sawai S, Shimono A, Wakamatsu Y, Palmes C, Hanaoka K, Kondoh H. 1993. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 117:1445-1455.
108. Schuhmacher M, Staege MS, Pajic A, Polack A, Weidle UH, Bornkamm GW, Eick D, Kohlhuber F. 1999. Control of cell growth by c-Myc in the absence of cell division. Curr Biol 9:1255-1258.
109. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. 2000. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 14:2501-2514.
110. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massague J. 2001. TGF-beta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 3:400-408.
111. Shen-Li H, O'Hagan RC, Hou H, Jr, Horner JW, 2nd, Lee HW, DePinho RA. 2000. Essential role for Max in early embryonic growth and development. Genes Dev 14:17-22.
112. Shu W, Guttentag S, Wang Z, Andl T, Ballard P, Lu MM, Piccolo S, Birchmeier W, Whitsett JA, Millar SE, Morrisey EE. 2005. Wnt/beta-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung. Dev Biol 283:226-239.
113. Smith CL, Peterson CL. 2005. ATP-dependent chromatin remodeling. Curr Top Dev Biol 65:115-148.
114. Solloway MJ, Robertson EJ. 1999. Early embryonic lethality in Bmp5;Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development 126:1753-1768.
115. Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Moroy T, Bartek J, Massague J, Hanel F, Eilers M. 2001. Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 3:392-399.
116. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF. 1992. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 6:2235-2247.
117. Sun X, Mariani FV, Martin GR. 2002. Functions of FGF signalling from the apical ectodermal ridge in limb development. Nature 418:501-508.
118. te Welscher P, Fernandez-Teran M, Ros MA, Zeller R. 2002a. Mutual genetic antagonism involving GLI3 and dHAND prepatterns the vertebrate limb bud mesenchyme prior to SHH signaling. Genes Dev 16:421-426.
119. te Welscher P, Zuniga A, Kuijper S, Drenth T, Goedemans HJ, Meijlink F, Zeller R. 2002b. Progression of vertebrate limb development through SHH-mediated counteraction of GLI3. Science 298:827-830.
120. Tickle C. 2003. Patterning systems-from one end of the limb to the other. Dev Cell 4:449-458.
121. Toyo-oka K, Hirotsune S, Gambello MJ, Zhou ZQ, Olson L, Rosenfeld MG, Eisenman R, Hurlin P, Wynshaw-Boris A. 2004. Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome. Hum Mol Genet 13:1057-1067.
122. Trumpp A, Refaeli Y, Oskarsson T, Gasser S, Murphy M, Martin GR, Bishop JM. 2001. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414:768-773.
123. Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V, Krause A, Leissner P, Puisieux A. 2004. Oncogenic cooperation between H-Twist and N-Myc overrides fail-safe programs in cancer cells. Cancer Cell 6:625-630.
124. van Bokhoven H, Celli J, van Reeuwijk J, RinneT, Glaudemans B, van Beusekom E, Rieu P, Newbury-Ecob RA, Chiang C, Brunner HG. 2005. MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome. Nat Genet 37:465-467.
125. Vervoorts J, Luscher-Firzlaff JM, Rottmann S, Lilischkis R, Waisemann G, Dohmann K, Austen M, Luscher B. 2003. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep 4:484-490.
126. von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI, Soderberg O, Kerppola TK, Larsson LG. 2003. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 11:1189-1200.
127. Walker W, Zhou ZQ, Ota S, Wynshaw-Boris A, Hurlin PJ. 2005. Mnt-Max to Myc-Max complex switching regulates cell cycle entry. J Cell Biol 169:405-413.
128. Wanzel M, Herold S, Eilers M. 2003. Transcriptional repression by Myc. Trends Cell Biol 13:146-150.
129. Welcker M, Orian A, Grim JA, Eisenman RN, Clurman BE. 2004a. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr Biol 14:1852-1857.
130. Welcker M, Orian A, Jin J, Grim JA, Harper JW, Eisenman RN, Clurman BE. 2004b. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 101:9085-9090.
131. White PJ. 2005. RNA polymerases I and III, growth control and cancer. Nat Rev Mol Cell Biol 6:69-78.
132. Wood MA, McMahon SB, Cole MD. 2000. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell 5:321-330.
133. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, Eilers M, Leon J, Larsson LG. 2003. Myc represses differentiation-induced P21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22:351-360.
134. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI. 2004. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 23:2116-2125.
135. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, Sears R. 2004. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6:308-318.
136. Zanet J, Pibre S, Jacquet C, Ramirez A, de Alboran IM, Gandarillas A. 2005. Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification. J Cell Sci 118:1693-1704.
137. Zervos AS, Gyuris J, Brent R. 1993. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223-232.
138. Zhang H, Bradley A. 1996. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122:2977-2986.
139. Zhou ZQ, Hurlin PJ. 2001. The interplay between Mad and Myc in proliferation and differentiation. Trends Cell Biol 11: S10-S14.
140. Zimmerman KA, Yancopoulos GD, Collum RG, Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran-Allerand D, Gee CE, Minna JD, Alt FW. 1986. Differential expression of myc family genes during murine development. Nature 319:780-783.